Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519130 | SCV000619233 | uncertain significance | not provided | 2023-11-10 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000519130 | SCV001416243 | likely benign | not provided | 2024-10-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001829495 | SCV002093101 | uncertain significance | Usher syndrome type 1F | 2019-11-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004537877 | SCV004710280 | uncertain significance | PCDH15-related disorder | 2023-10-27 | no assertion criteria provided | clinical testing | The PCDH15 c.2897G>C variant is predicted to result in the amino acid substitution p.Arg966Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.15% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-55721624-C-G). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |